Machiels Alec's Form 4 filing
Apellis Pharmaceuticals, Inc. (APLS) · filed Nov 17, 2021
- Accession no.
- 0001127602-21-029466
- Filed
- Nov 17, 2021
- Trade date
- Nov 4-15, 2021
- Filing delay
- 13 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $235.5K. It was filed 13 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Machiels AlecCIK 0001496687 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 4, 2021 | Common Stock | MOption exerciseAcquired | +3,000 | $2.67 | +$8,010 | 672,544 | Direct | |
| Nov 4, 2021 | Common Stock | SSaleDisposed | −3,000 | $35.00 | −$105,000 | 669,544 | Direct | |
| Nov 15, 2021 | Common Stock | MOption exerciseAcquired | +3,000 | $2.67 | +$8,010 | 672,544 | Direct | |
| Nov 15, 2021 | Common Stock | SSaleDisposed | −3,000 | $43.50 | −$130,500 | 669,544 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 4, 2021 | Common Stock | MOption exerciseDisposed | −3,000 | $0.00 | $0 | 134,529 | Direct | |
| Nov 15, 2021 | Common Stock | MOption exerciseDisposed | −3,000 | $0.00 | $0 | 131,529 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.